Managing and preventing blood-borne viral infection transmission in assisted reproduction: a Canadian Fertility and Andrology Society clinical practice guideline.
Reprod Biomed Online
; 41(2): 203-216, 2020 Aug.
Article
de En
| MEDLINE
| ID: mdl-32546334
ABSTRACT
Fertility care providers have an obligation to provide safe and effective care to patients. When a user of assisted reproductive technology (ART) is living with a blood-borne viral infection (BBVI HIV, hepatitis C or hepatitis B), physicians and ART laboratory personnel need to know the requirements for providing quality care. Recent developments in the treatment of BBVI and understanding of transmission have changed these requirements. This guideline from the Canadian Fertility and Andrology Society (CFAS) provides comprehensive, evidence-based guidelines for reducing horizontal transmission and cross-contamination in the ART setting.
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Antiviraux
/
Infections à VIH
/
Prévention des infections
/
Hépatite C
/
Techniques de reproduction assistée
/
Infections transmissibles par le sang
/
Hépatite B
Type d'étude:
Guideline
Limites:
Female
/
Humans
Pays/Région comme sujet:
America do norte
Langue:
En
Journal:
Reprod Biomed Online
Sujet du journal:
MEDICINA REPRODUTIVA
Année:
2020
Type de document:
Article